Abellanas Miguel A, Purnapatre Maitreyee, Burgaletto Chiara, Schwartz Michal
Department of Brain Sciences, Weizmann Institute of Science, Rehovot, Israel.
Nat Neurosci. 2025 Mar;28(3):436-445. doi: 10.1038/s41593-024-01847-5. Epub 2025 Jan 6.
The central nervous system (CNS) is endowed with its own resident innate immune cells, the microglia. They constitute approximately 10% of the total cells within the CNS parenchyma and act as 'sentinels', sensing and mitigating any deviation from homeostasis. Nevertheless, under severe acute or chronic neurological injury or disease, microglia are unable to contain the damage, and the reparative activity of monocyte-derived macrophages (MDMs) is required. The failure of the microglia under such conditions could be an outcome of their prolonged exposure to hostile stimuli, leading to their exhaustion or senescence. Here, we describe the conditions under which the microglia fall short, focusing mainly on the context of Alzheimer's disease, and shed light on the functions performed by MDMs. We discuss whether and how MDMs engage in cross-talk with the microglia, why their recruitment is often inadequate, and potential ways to augment their homing to the brain in a well-controlled manner.
中枢神经系统(CNS)拥有自身固有的先天性免疫细胞——小胶质细胞。它们约占中枢神经系统实质内细胞总数的10%,并充当“哨兵”,感知并缓解任何偏离内稳态的情况。然而,在严重急性或慢性神经损伤或疾病的情况下,小胶质细胞无法控制损伤,需要单核细胞衍生巨噬细胞(MDM)的修复活性。在这种情况下,小胶质细胞的功能失效可能是它们长期暴露于有害刺激的结果,导致它们耗竭或衰老。在这里,我们描述了小胶质细胞功能不足的情况,主要聚焦于阿尔茨海默病的背景,并阐明了MDM所发挥的功能。我们讨论了MDM是否以及如何与小胶质细胞进行相互作用,为什么它们的募集往往不足,以及以可控方式增强它们归巢至大脑的潜在方法。